{"schema_version":"secwatch.filing_event.v1","accession":"0001398733-25-000030","form_type":"8-K","ticker":"AQST","cik":"0001398733","company_name":"Aquestive Therapeutics, Inc.","filed_at":"2025-11-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.306603+00:00","generated_at":"2026-05-16T23:34:41.212975+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Aquestive Therapeutics files Q3 2025 investor presentation; no specific financial details disclosed in filing text","bullets":["Form 8-K filed on November 6, 2025, under Item 7.01 for Regulation FD disclosure.","Investor presentation attached as Exhibit 99.1, titled 'Q3 Earnings Supplemental Materials'.","Presentation available on company's website, but full content not included in provided filing text."],"urls":{"canonical":"https://secwatch.observer/filing/0001398733-25-000030","json":"https://secwatch.observer/filing/0001398733-25-000030.json","markdown":"https://secwatch.observer/filing/0001398733-25-000030.md","text":"https://secwatch.observer/filing/0001398733-25-000030.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1398733/000139873325000030/0001398733-25-000030-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1398733/000139873325000030/aqst-20251106.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T23:34:41.212975+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}